Related Experiment Video
Updated: Jun 15, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Complexity in influenza virus targeted drug design: interaction with human sialidases
Leonard M G Chavas1, Ryuichi Kato, Nobuhiro Suzuki
1PF-IMSS-KEK-SBRC, Ibaraki 305-0801, Japan.
Abstract:
With the global spread of the pandemic H1N1 and the ongoing pandemic potential of the H5N1 subtype, the influenza virus represents one of the most alarming viruses spreading worldwide. The influenza virus sialidase is an effective drug target, and a number of inhibitors are clinically effective against the virus (zanamivir, oseltamivir, peramivir). Here we report structural and biochemical studies of the human cytosolic sialidase Neu2 with influenza virus sialidase-targeting drugs and related compounds.
Related Concept Videos
Inhibitors Of Virion Release
Influenza
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Leaky Scanning
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

